Sulphadoxine-pyrimethamine therapy in Crohn's disease.
D000328:Adult; D002986:Clinical Trials as Topic; D003424:Crohn Disease / Q000188:drug therapy* / Q000209:etiology; D004311:Double-Blind Method; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000150:complications; D009170:Nontuberculous Mycobacteria / Q000187:drug effects; D011739:Pyrimethamine / Q000627:therapeutic use*; D013413:Sulfadoxine / Q000627:therapeutic use*; D013424:Sulfanilamides / Q000627:therapeutic use*
D004338:Drug Combinations; D013424:Sulfanilamides; D013413:Sulfadoxine; D011739:Pyrimethamine